DrugInfoSys

Pneumococcal Vaccine

Drug #972

Pneumococcal Vaccine is a mixture of purified capsular polysaccharides from the 23 types of S. pneumoniae that are resposible for 90% of all pneumococcal infections. Pneumococcal Vaccine is used to provide selective immunity against infection caused by pneumococci in person over 2 years of age.

← Previous drugNext drug →

Primary Characteristics

It is of Natural origin and belongs to Polysaccharides.

It is classified in Vaccines , Vaccines pharmacological group. It is also classified under Toxoids .

Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Pneumococcal Vaccine.

Molecular structure of Pneumococcal Vaccine

Pharmacokinetics

None recorded.

Advertisement

Indications

Pneumococcal Vaccine is primarily indicated in conditions like CSF leak, Pneumonia.

Pneumococcal Vaccine is also indicated for secondary conditions like AIDS.

Contraindications

Pneumococcal Vaccine is contraindicated in conditions like Pregnancy, Hypersensitivity to any component of product.

Dosage

Pneumococcal Vaccine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
25 ug25 ug—IM(or 0.5 ml) . Same dose for children over 2 years of age
Paediatric Dosage (20kg)
25 ug25 ug—Intra Muscular As Required
25 ug25 ug—Subcutaneous As Required
Neonatal Dosage (3kg)
0 – 0——Not recommended in this age group

Drug Interactions

None recorded.

Side Effects

Pneumococcal Vaccine is known to cause more or less tolerable side effects which are usually transient. These include Allergic reactions, Fever, Rashes , Redness at injection site, Soreness .

Warnings / Precautions

Vaccination should be postponed in patients suffering from any acute illness. Immunization should not be carried out in individuals who have previously had a severe local or general reaction to the vaccine. Some vaccine contains antibiotics in small amount and should not be given to patients with history of anaphylaxis to the agent used. It should be given atleast 10 days before starting immunosuppressive therapy or be delayed until atleast 6 months after completion of therapy. It is not recommended to use in children under 2yr of age.

Interference in Pathology

Pneumococcal Vaccine may interfere in the diagnosis of None well documented.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Inj
2 mcg/0.5ml25 mcg/0.5ml

Storage Conditions

Pneumococcal Vaccine should be stored SC Inj, IM Inj.

Drug Classification

  1. 1.19.3.2 — Vaccines for specific groups of individuals

Manufacturers

Manufacturers of Pneumococcal Vaccine in Pakistan:

AventisGSKPfizer